Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

NZ Biomedical Researchers Showcase Their Work

New Zealand Biomedical Researchers Showcase Their Work

Leading New Zealand biomedical researchers are show-casing their work to international pharmaceutical companies at a meeting opening in Wellington today.

“The New Zealand Biomedical R&D Showcase” is sponsored by the Minister for Research, Science and Technology, Pete Hodgson. It is jointly chaired by the Chairman of the Researched Medicines Industry (RMI), Richard Nottage, and Dr Paul Reynolds, Chief Policy Adviser at the Ministry of Research, Science and Technology.

Dr Reynolds said, “The meeting is an opportunity for New Zealand researchers to inform the international pharmaceutical industry about the scope of our biomedical research. It will explore the potential to develop and grow our biomedical research industry.”

Over the next two days the meeting will cover the New Zealand policy environment, drug discovery and development, clinical research, gene and protein-based research, and animal-based biomedical research that takes place in this country.

RMI Chairman Richard Nottage said, “It has taken considerable effort on the part of the pharmaceutical industry to bring together some of their most senior research directors in support of the Government’s knowledge economy drive.

“We hope this meeting represents the first of similar, but smaller, commercially-focussed discussions which will need to occur if the New Zealand biotech industry is to grow significantly and to have a viable, long term future.

The presenters have been drawn from a variety of New Zealand’s public and private research entities. They include notable figures such as cancer researcher Prof William Denny, Genesis Chief Executive, Dr Jim Watson, Malaghan Institute Director, Professor Graham Le Gros, and Dean of the Auckland Medical School, Professor Peter Gluckman.

The participants include pharmaceutical company research directors from the United States, United Kingdom, Australia and New Zealand representing major international pharmaceutical companies, such as Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Pfizer and Wyeth.

Ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

BusinessDesk: Body massages and Uber are in, DVDs are out, says Stats NZ

Statistics New Zealand has rejigged the consumers price index basket in its latest three-year review, adding body massages, Airbnb and Uber and removing DVD and Blu-Ray players…More>>

ALSO:


StuffMe: Commerce Commission Welcomes Dismissal Of Merger Appeal

In a summary of their judgment released today, Justice Dobson and lay member Professor Martin Richardson dismissed the appellants’ process criticisms and found the Commission was entitled to place significant weight on the prospect of reduced quality of the products produced by the merged entity. More>>

ALSO:

Digital Futures: New Chief Technology Officer Role Created

Communications Minister Clare Curran has called for expressions of interest for the new role of Chief Technology Officer position to help drive a forward-looking digital agenda for New Zealand. More>>

Dry: Beef + Lamb Launches Drought Resources

The resources include a fact sheet outlining strategies to manage and mitigate the effects of drought, coping with stress on the farm and advice on feed requirements and animal welfare during the dry period. More>>

ALSO:

InternetNZ: Net Neutrality Failure In US "Will Hurt All Users"

InternetNZ Chief Executive Jordan Carter has condemned the decision by the United States communications regulator to undo 2015 open Internet rules, warning that all Internet users will end up worse off as a result. More>>

ALSO: